Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 3/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL669338 | 0.96 | ABCB1 (0.75) | ABCB1 | |
| SCHEMBL8998705 | 0.88 | ABCB1 (0.78) | ABCB1 | |
| SCHEMBL8999019 | 0.86 | ABCB1 (0.69) | ABCB1 | |
| SCHEMBL8998880 | 0.85 | ABCB1 (0.73) | ABCB1 | |
| SCHEMBL8998870 | 0.85 | ABCB1 (0.73) | ABCB1 | |
| SCHEMBL8383526 | 0.85 | ABCB1 (0.80) | ABCB1 | |
| SCHEMBL8383648 | 0.85 | ABCB1 (0.80) | ABCB1 | |
| SCHEMBL8998754 | 0.84 | ABCB1 (0.72) | ABCB1 | |
| SCHEMBL5062707 | 0.83 | ABCB1 (0.77) | ABCB1 | |
| SCHEMBL8998770 | 0.82 | ABCB1 (0.76) | ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120046322-A1 | Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex | INTREXON CORPORATION (US) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046322-A1 | Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex | NR2E3, NR5A1, NR5A2 | ABCB1 1365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.